London · Delayed Price · Currency is GBP · Price in GBX Spirax Group Earnings Call Transcripts
Fiscal Year 2025
-
Achieved 5% organic sales growth and 6% adjusted operating profit growth, with all segments improving margins despite macroeconomic headwinds. Completed restructuring delivered GBP 40 million in annualized savings, fueling investment in digital, operational, and growth initiatives.
-
Organic sales and profit growth outpaced industrial production, with strong demand in biofarm, semicon, and process industries. Margins improved across all segments, restructuring is on track, and guidance for full-year growth is reiterated despite macroeconomic headwinds.
Fiscal Year 2024
-
Organic sales grew 4% year-over-year, outpacing global IP, with all segments contributing and margins maintained despite macro headwinds. 2025 guidance targets similar organic growth, margin improvement, and continued investment in digital and decarbonization, supported by restructuring and operational efficiencies.
-
The group is leveraging its three core businesses to capitalize on global megatrends, especially decarbonization, expanding its addressable market by 60%. Operational improvements, digital transformation, and proprietary technologies are set to drive margin expansion and sustained organic growth, with a focus on shareholder returns and long-term value creation.
-
Organic sales grew 1.3% in H1 2024, but reported results were impacted by FX headwinds and weaker demand in China. Operational improvements and investments continue, with stronger organic growth and stable margins expected in H2, despite ongoing macroeconomic and FX challenges.